HCV-NUKLEOSIDINHIBITOR

European patent · EP2084175 · Deleted

Register entry

Publication number
EP2084175
Application number
EP07820934
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 4, 2007
Published
Aug 5, 2009
Granted
Dec 29, 2010
Deleted
Oct 31, 2018
Reason
Annual fee unpaid
IPC classes
C07H 19/073 (2006.01)
A61K 31/513 (2006.01)
A61P 31/12 (2006.01)
Priority
US 850926 P 10.10.2006
PCT application
PCT/EP2007/060557 04.10.2007
PCT publication
WO2008/043704 17.04.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 22, 2019

    Deleted, fee unpaid

    Published in Swissreg on 22.05.2019

  2. Sep 10, 2013

    Transferred

    Owner
    Medivir AB, P.O. Box 1086, 141 22 Huddinge, Sweden → Medivir AB, P.O. Box 1086, 141 22 Huddinge, Sweden, Janssen Products, LP, 800/850 Ridgeview Drive, Horsham, PA 19044, USA

    Published in Swissreg on 10.09.2013

  3. May 4, 2011

    Agent entered

    Representative
    Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano

    Published in Swissreg on 04.05.2011

  4. Dec 29, 2010

    Granted

    Published in Swissreg on 29.12.2010

Parties

Inventor

JOHANSSON, Nils-Gunnar

14144 Huddinge, SE

KALAYANOV, Genadiy

14144 Huddinge, SE

MARTIN, Joseph Armstrong

Harpenden Hertfordshire AL5 2BN, GB

SMITH, David Bernard

San Mateo, CA 94403, US

WINQVIST, Anna

14144 Huddinge, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.